According to Rastgoo [23], the connection between RBPMS and miR-138 played a role in the drug sensitivity of multiple myeloma (MM) with the influence of the enhancer of zeste homolog (EZH2). This evidence concerns the gene EZH2 and Miyoshi myopathy.